...Luminex increased its bid to acquire fellow diagnostic company Nanosphere to $1.70 per share in cash...
...or about $77 million. Luminex increased its bid from $1.35 per share in cash after Nanosphere...
...test. Nanosphere and Luminex reported $21.1 million and $237.7 million, respectively, in revenue last year. Nanosphere Inc....

...unit) Shares after offering: 10.5 million Investor: Existing investors Underwriters: H.C. Wainwright; Joseph Gunnar Note: Nanosphere...

...Up to $10 million Units: TBD Price prior: $2.01 Underwriters: H.C. Wainwright; Joseph Gunnar Note: Nanosphere...

...be raised: Up to $25 million Units: TBD Price Prior: $2.01 Underwriter: H.C. Wainwright Note: Nanosphere...

...FDA granted 510(k) clearance to Nanosphere’s Verigene Respiratory Pathogens Flex Nucleic Acid Test (RP Flex) to...
...or in various user defined subsets. The test runs on the company’s automated Verigene System. Nanosphere Inc....

...Type: Debt financing Raised: $20 million Investors: Life Sciences Alternative Funding; SWK Funding LLC Note: Nanosphere...
...down the remaining $10 million within a year, based on revenue milestones and other conditions. Nanosphere...

...10/23/14 $12.9 NA $66.0 NA DBV Technologies S.A. (Euronext:DBV; NASDAQ:DBVT) 10/22/14 $106.5 $407.8 $1,023.5 151% Nanosphere Inc....